Artic Therapeutics is an Iceland-based drug discovery and development company that is focused on identifying the genetic underpinnings of both rare and common diseases to develop novel and innovative therapies
Arctic Therapeutics has raised €39M across 2 funding rounds from 10 investors, most recently a Series A round in Jan 2025. Based in Akureyri, Iceland; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-01-22 | Series A | €27M | Cerebrum DAO,Chemometec,EIC Fund,Family Offices,Institutional investors,Kaldbakur+3 more | View deal → |
| 2022-12-29 | Grant | €12M | European Innovation Council (EIC) Accelerator Programme | View deal → |
